FDA Needs To Weigh Foreign Inspections More Heavily - SOCMA
This article was originally published in The Tan Sheet
Executive Summary
Despite plans to increase overseas inspections for fiscal 2010, FDA's refusal to risk-rank domestic and foreign manufacturers together puts U.S. firms at a disadvantage, according to the Society of Chemical Manufacturers and Affiliates